CANGRELOR

CANGRELOR was reported 404 times

CANGRELOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY VENOUS HYPERTENSION 1 0.0769
1 PLATELET ADHESIVENESS DECREASED 1 0.0769
2 VASCULAR ACCESS SITE HAEMORRHAGE 9 0.0559
3 EOSINOPHIL CATIONIC PROTEIN INCREASED 1 0.0556
4 PROCEDURAL SHOCK 1 0.0278
5 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 2 0.0238
6 PNEUMONIA PSEUDOMONAS AERUGINOSA 1 0.0217
7 CORONARY REVASCULARISATION 3 0.0190
8 RESTENOSIS 1 0.0172
9 ADMINISTRATION SITE INDENTATION 1 0.0161
10 VASCULAR STENT THROMBOSIS 32 0.0157
11 BURKHOLDERIA INFECTION 1 0.0120
12 GRAFT HAEMORRHAGE 1 0.0116
13 TONGUE PIGMENTATION 1 0.0114
14 TRACHEAL HAEMORRHAGE 4 0.0114
15 BURKHOLDERIA TEST POSITIVE 1 0.0081
16 DUODENITIS HAEMORRHAGIC 1 0.0072
17 ANASTOMOTIC ULCER HAEMORRHAGE 1 0.0070
18 PRODUCT RECONSTITUTION ISSUE 2 0.0063
19 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0055
20 PLATELET FUNCTION TEST ABNORMAL 1 0.0045
21 TRAUMATIC LIVER INJURY 1 0.0043
22 VESSEL PUNCTURE SITE HAEMORRHAGE 1 0.0041
23 GRAFT THROMBOSIS 1 0.0038
24 TRAUMATIC HAEMOTHORAX 1 0.0036
25 CATHETER SITE HAEMATOMA 1 0.0034
26 SINOATRIAL BLOCK 2 0.0034
27 COAGULATION TIME ABNORMAL 1 0.0033
28 BRONCHIAL HAEMORRHAGE 1 0.0032
29 RESPIRATORY GAS EXCHANGE DISORDER 1 0.0027
30 VASCULAR STENT OCCLUSION 1 0.0025
31 CORONARY ARTERY DISSECTION 2 0.0023
32 MIXED LIVER INJURY 7 0.0023
33 PELVIC HAEMATOMA 1 0.0023
34 CEREBRAL HYPOPERFUSION 1 0.0021
35 GASTRITIS HAEMORRHAGIC 3 0.0020
36 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0020
37 INCORRECT DRUG ADMINISTRATION RATE 8 0.0019
38 PRODUCT NAME CONFUSION 2 0.0018
39 ARTERIAL HAEMORRHAGE 2 0.0017
40 DOSE CALCULATION ERROR 1 0.0017
41 HYPERTENSIVE EMERGENCY 2 0.0017
42 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
43 CORONARY ARTERY RESTENOSIS 1 0.0017
44 RETROPERITONEAL HAEMORRHAGE 4 0.0016
45 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
46 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
47 PEPTIC ULCER HAEMORRHAGE 1 0.0014
48 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
49 PELVIC VENOUS THROMBOSIS 2 0.0014
50 VASOGENIC CEREBRAL OEDEMA 1 0.0014
51 BRAIN CONTUSION 1 0.0014
52 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
53 SPUTUM CULTURE POSITIVE 1 0.0012
54 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
55 SYNCOPE VASOVAGAL 1 0.0012
56 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
57 VENA CAVA THROMBOSIS 2 0.0012
58 CATHETER SITE SWELLING 1 0.0011
59 CARDIOGENIC SHOCK 15 0.0010
60 HAEMOTHORAX 3 0.0010
61 PULMONARY HAEMORRHAGE 8 0.0010
62 HEPARIN-INDUCED THROMBOCYTOPENIA 5 0.0010
63 SYSTOLIC DYSFUNCTION 1 0.0009
64 PERICARDIAL HAEMORRHAGE 2 0.0009
65 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
66 CATHETER SITE HAEMORRHAGE 2 0.0008
67 INFUSION SITE IRRITATION 1 0.0008
68 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
69 PACKED RED BLOOD CELL TRANSFUSION 1 0.0008
70 INTRACRANIAL ANEURYSM 3 0.0007
71 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
72 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
73 HAEMORRHAGE INTRACRANIAL 10 0.0007
74 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
75 VENTRICULAR FIBRILLATION 7 0.0006
76 BRADYARRHYTHMIA 1 0.0006
77 POST PROCEDURAL HAEMATOMA 1 0.0006
78 RECALLED PRODUCT 1 0.0006
79 VASCULAR PSEUDOANEURYSM 1 0.0006
80 THROMBOPHLEBITIS 2 0.0006
81 MOUTH HAEMORRHAGE 4 0.0005
82 PROCEDURAL HAEMORRHAGE 2 0.0005
83 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
84 CORONARY ARTERY THROMBOSIS 1 0.0005
85 ATRIAL THROMBOSIS 1 0.0005
86 INFUSION SITE BRUISING 1 0.0005
87 EOSINOPHILIA 8 0.0005
88 RETROPERITONEAL HAEMATOMA 1 0.0005
89 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
90 BLOOD LOSS ANAEMIA 1 0.0004
91 NEUROLOGICAL DECOMPENSATION 1 0.0004
92 CARDIAC TAMPONADE 2 0.0004
93 HAEMORRHAGIC STROKE 3 0.0004
94 COMPARTMENT SYNDROME 1 0.0004
95 SUBDURAL HAEMORRHAGE 1 0.0004
96 CLONUS 1 0.0004
97 VENTRICULAR TACHYCARDIA 6 0.0004
98 DUODENAL ULCER HAEMORRHAGE 1 0.0003
99 BRAIN HERNIATION 1 0.0003
100 CRANIOCEREBRAL INJURY 1 0.0003
101 BRAIN DEATH 1 0.0003
102 INFUSION SITE EXTRAVASATION 2 0.0003
103 INFUSION SITE SWELLING 2 0.0003
104 VENTRICULAR HYPOKINESIA 1 0.0003
105 CEREBRAL HAEMORRHAGE 11 0.0003
106 THROMBOSIS IN DEVICE 1 0.0003
107 DRUG LEVEL DECREASED 3 0.0003
108 SUBARACHNOID HAEMORRHAGE 3 0.0003
109 TRANSFUSION 3 0.0003
110 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
111 STEVENS-JOHNSON SYNDROME 6 0.0003
112 GASTRIC HAEMORRHAGE 3 0.0003
113 ATRIOVENTRICULAR BLOCK 2 0.0003
114 HAEMORRHAGE 26 0.0002
115 PERIPHERAL ISCHAEMIA 1 0.0002
116 PRODUCT PREPARATION ERROR 5 0.0002
117 EXTRAVASATION 1 0.0002
118 ACUTE CORONARY SYNDROME 2 0.0002
119 PULMONARY FUNCTION TEST DECREASED 1 0.0002
120 LUNG INFILTRATION 2 0.0002
121 CARDIAC ARREST 18 0.0002
122 ARTERIOSCLEROSIS 2 0.0002
123 INCORRECT DOSAGE ADMINISTERED 1 0.0002
124 HAEMATOMA 5 0.0002
125 PNEUMOTHORAX 3 0.0002
126 HYDROCEPHALUS 1 0.0002
127 OFF LABEL USE 160 0.0002
128 INTESTINAL ISCHAEMIA 1 0.0002
129 GASTRIC ULCER HAEMORRHAGE 1 0.0002
130 INTRACRANIAL PRESSURE INCREASED 1 0.0002
131 NEUROLOGICAL SYMPTOM 1 0.0002
132 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
133 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
134 DRUG RESISTANCE 4 0.0002
135 PRODUCT PREPARATION ISSUE 1 0.0002
136 CARDIAC FAILURE ACUTE 1 0.0001
137 PRODUCT ADMINISTRATION ERROR 3 0.0001
138 COLITIS ISCHAEMIC 1 0.0001
139 METASTASIS 1 0.0001
140 ACUTE MYOCARDIAL INFARCTION 4 0.0001
141 TROPONIN INCREASED 1 0.0001
142 HYPERTHERMIA 1 0.0001
143 ACIDOSIS 1 0.0001
144 SHOCK 3 0.0001
145 PERICARDIAL EFFUSION 3 0.0001
146 EJECTION FRACTION DECREASED 2 0.0001
147 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
148 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
149 ATRIAL FLUTTER 1 0.0001
150 PRODUCT COMPLAINT 3 0.0001
151 HAEMATURIA 4 0.0001
152 DELIRIUM 4 0.0001
153 CARDIAC FAILURE 9 0.0001
154 NO ADVERSE EVENT 20 0.0001
155 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
156 HAEMATOCRIT DECREASED 2 0.0001
157 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
158 THROMBOSIS 8 0.0001
159 DRUG ADMINISTRATION ERROR 3 0.0001
160 NEPHROPATHY TOXIC 1 0.0001
161 THERAPY NON-RESPONDER 4 0.0001
162 POST PROCEDURAL HAEMORRHAGE 1 0.0001
163 ILL-DEFINED DISORDER 5 0.0001
164 RESPIRATORY DEPRESSION 1 0.0001
165 BRAIN OEDEMA 1 0.0001
166 BRADYCARDIA 4 0.0001
167 EYE HAEMORRHAGE 1 0.0001
168 CORONARY ARTERY OCCLUSION 1 0.0001
169 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
170 HAEMOPTYSIS 2 0.0001
171 THROMBOCYTOPENIA 8 0.0001
172 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
173 SUBDURAL HAEMATOMA 1 0.0001
174 PARAESTHESIA ORAL 1 0.0001
175 PULMONARY OEDEMA 3 0.0001
176 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
177 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
178 TYPE 2 DIABETES MELLITUS 2 0.0001
179 HEMIPARESIS 1 0.0001
180 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
181 HYPOXIA 2 0.0001
182 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
183 ACUTE RESPIRATORY FAILURE 1 0.0001
184 ERUCTATION 1 0.0001
185 PRESCRIBED OVERDOSE 1 0.0001
186 FEEDING DISORDER 1 0.0000
187 HAEMOGLOBIN DECREASED 5 0.0000
188 CARDIO-RESPIRATORY ARREST 2 0.0000
189 RECTAL HAEMORRHAGE 2 0.0000
190 GLOSSODYNIA 1 0.0000
191 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
192 CHROMATURIA 1 0.0000
193 CEREBROVASCULAR ACCIDENT 7 0.0000
194 RESPIRATORY FAILURE 3 0.0000
195 MYOCARDIAL INFARCTION 7 0.0000
196 PNEUMONIA ASPIRATION 1 0.0000
197 ANAPHYLACTIC SHOCK 1 0.0000
198 UNRESPONSIVE TO STIMULI 1 0.0000
199 RESPIRATORY DISTRESS 1 0.0000
200 DRUG ABUSE 3 0.0000
201 HYPOTENSION 7 0.0000
202 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
203 HEPATIC FAILURE 1 0.0000
204 CORONARY ARTERY DISEASE 1 0.0000
205 EXPOSURE DURING PREGNANCY 2 0.0000
206 HEAD INJURY 1 0.0000
207 DRUG INTERACTION 5 0.0000
208 CONTUSION 3 0.0000
209 LACTIC ACIDOSIS 1 0.0000
210 INFUSION RELATED REACTION 2 0.0000
211 HYPERGLYCAEMIA 1 0.0000
212 UNDERDOSE 2 0.0000
213 CHEST PAIN 5 0.0000
214 EPISTAXIS 2 0.0000
215 INCORRECT DOSE ADMINISTERED 6 0.0000
216 DEATH 22 0.0000
217 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
218 CARDIAC FAILURE CONGESTIVE 2 0.0000
219 RENAL FAILURE ACUTE 1 0.0000
220 DRUG INEFFECTIVE 31 0.0000
221 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
222 DYSPNOEA 12 0.0000
223 COMA 1 0.0000
224 PRODUCTIVE COUGH 1 0.0000
225 RASH ERYTHEMATOUS 1 0.0000
226 PANCREATITIS 1 0.0000
227 DRUG EFFECT DECREASED 1 0.0000
228 TREATMENT NONCOMPLIANCE 1 0.0000
229 ANAPHYLACTIC REACTION 1 0.0000
230 MEDICATION ERROR 1 0.0000
231 SEPSIS 2 0.0000
232 OXYGEN SATURATION DECREASED 1 0.0000
233 FLATULENCE 1 0.0000
234 PRODUCT USE ISSUE 3 0.0000
235 HYPERHIDROSIS 2 0.0000
236 BLOOD CREATININE INCREASED 1 0.0000
237 RENAL FAILURE 2 0.0000
238 BLOOD PRESSURE DECREASED 1 0.0000
239 PRODUCT QUALITY ISSUE 2 0.0000
240 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
241 ACUTE KIDNEY INJURY 2 0.0000
242 RENAL IMPAIRMENT 1 0.0000
243 ADVERSE EVENT 1 0.0000
244 CHEST DISCOMFORT 1 0.0000
245 PLATELET COUNT DECREASED 1 0.0000
246 OVERDOSE 2 0.0000
247 MUSCULAR WEAKNESS 1 0.0000
248 OEDEMA PERIPHERAL 1 0.0000
249 VISUAL IMPAIRMENT 1 0.0000
250 CONDITION AGGRAVATED 2 0.0000
251 BLOOD PRESSURE INCREASED 1 0.0000
252 HOSPITALISATION 1 0.0000
253 HEADACHE 4 0.0000
254 URTICARIA 1 0.0000
255 ABDOMINAL DISCOMFORT 1 0.0000
256 MYALGIA 1 0.0000
257 MUSCLE SPASMS 1 0.0000
258 HYPERSENSITIVITY 1 0.0000
259 ANAEMIA 1 0.0000
260 GAIT DISTURBANCE 1 0.0000
261 ERYTHEMA 1 0.0000
262 RASH 2 0.0000
263 CONSTIPATION 1 0.0000
264 DECREASED APPETITE 1 0.0000
265 VOMITING 2 0.0000
266 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
267 NAUSEA 3 0.0000
268 INSOMNIA 1 0.0000
269 COUGH 1 0.0000
270 ANXIETY 1 0.0000
271 PRODUCT DOSE OMISSION ISSUE 1 0.0000
272 FALL 1 0.0000
273 ASTHENIA 1 0.0000
274 DIZZINESS 1 0.0000
275 PAIN 1 0.0000
276 DIARRHOEA 1 0.0000
277 FATIGUE 1 0.0000